Bifidobacteria
- SCIENTIFIC NAMES: Bifidobacterium adolescentis; Bifidobacterium animalis; Bifidobacterium bifidum; Bifidobacterium breve; Bifidobacterium infantis; Bifidobacterium lactis; Bifidobacterium longum
- INDICATIONS: Diarrhea, atopic eczema, candidiasis, colds and flu, hepatitis, hypercholesterolemia, lactose intolerance, ulcerative colitis, pouchitis, irritable bowel syndrome
- SYNONYM: Actinomycetaceae
- CLASS: Immunomodulator, Probiotic
- HALF-LIFE: N/A
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
PREGNANCY CATEGORY: N/A
Immune-deficient subjects or those with mucosal disease may experience serious adverse effects.
Bifidobacterium is often combined with Lactobacillus, Saccharomyces or Streptococcus thermophilus.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric